Total Payments
$4,448
2024 Payments
$661.25
Companies
34
Transactions
260
Medicare Patients
4,280
Medicare Billing
$221,823
Payment Breakdown by Category
Food & Beverage$4,418 (99.3%)
Education$29.99 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,418 | 259 | 99.3% |
| Education | $29.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $678.94 | 28 | $0 (2024) |
| AbbVie Inc. | $551.45 | 30 | $0 (2023) |
| Amgen Inc. | $459.67 | 24 | $0 (2024) |
| Novo Nordisk Inc | $410.98 | 29 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $325.97 | 27 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $247.08 | 18 | $0 (2021) |
| Allergan, Inc. | $242.23 | 14 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $215.36 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $205.48 | 10 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $190.90 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $661.25 | 27 | PFIZER INC. ($371.64) |
| 2023 | $296.35 | 15 | PFIZER INC. ($87.40) |
| 2022 | $557.20 | 28 | Bayer HealthCare Pharmaceuticals Inc. ($157.83) |
| 2021 | $837.11 | 48 | AbbVie Inc. ($325.33) |
| 2020 | $419.35 | 31 | Novo Nordisk Inc ($75.95) |
| 2019 | $512.38 | 34 | Merck Sharp & Dohme Corporation ($128.68) |
| 2018 | $275.13 | 19 | Allergan Inc. ($52.38) |
| 2017 | $888.96 | 58 | PFIZER INC. ($194.23) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Biological | ||||||
| 10/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $104.85 | General |
| Category: VACCINES | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 08/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $110.42 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Obesity | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Insulin Pump | ||||||
| 07/15/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: VACCINES | ||||||
| 06/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, PENBRAYA | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: VACCINES | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $126.20 | General |
| Category: VACCINES | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Obesity | ||||||
| 02/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 820 | 1,194 | $127,301 | $44,488 |
| 2022 | 22 | 1,039 | 1,497 | $154,954 | $54,330 |
| 2021 | 24 | 1,186 | 1,668 | $162,182 | $61,229 |
| 2020 | 27 | 1,235 | 1,737 | $184,638 | $61,776 |
Total Patients
4,280
Total Services
6,096
Medicare Billing
$221,823
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 173 | $41,520 | $13,287 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $11,160 | $9,031 | 80.9% |
| 77067 | Screening mammography | Office | 2023 | 32 | 32 | $9,600 | $2,836 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 58 | $8,700 | $2,763 | 31.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 34 | $2,380 | $2,332 | 98.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,950 | $1,818 | 36.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 28 | $4,200 | $1,721 | 41.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 25 | $3,750 | $1,567 | 41.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 82 | 131 | $9,170 | $1,335 | 14.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 83 | 155 | $1,550 | $1,302 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 35 | $1,050 | $1,029 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 80 | 132 | $3,300 | $989.30 | 30.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 58 | 69 | $5,175 | $905.28 | 17.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 24 | 24 | $7,920 | $881.04 | 11.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 28 | 43 | $2,236 | $707.78 | 31.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 22 | 23 | $1,886 | $638.22 | 33.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 44 | $1,540 | $409.36 | 26.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 23 | 36 | $3,960 | $318.24 | 8.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 21 | $1,092 | $196.74 | 18.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 13 | 14 | $1,092 | $192.14 | 17.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 14 | $420.00 | $118.96 | 28.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 11 | 13 | $650.00 | $107.77 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 216 | $51,840 | $17,054 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 80 | 80 | $12,400 | $10,193 | 82.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 102 | $15,300 | $5,261 | 34.4% |
About Dr. Alicia Cleaver, D.O
Dr. Alicia Cleaver, D.O is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1730409939.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alicia Cleaver, D.O has received a total of $4,448 in payments from pharmaceutical and medical device companies, with $661.25 received in 2024. These payments were reported across 260 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,418).
As a Medicare-enrolled provider, Cleaver has provided services to 4,280 Medicare beneficiaries, totaling 6,096 services with total Medicare billing of $221,823. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 06/10/2010
- Last Updated 05/27/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730409939
Products in Payments
- PREVNAR 20 (Biological) $345.77
- LINZESS (Drug) $287.06
- EVENITY (Biological) $281.41
- JANUVIA (Drug) $265.74
- ENTRESTO (Drug) $205.48
- Kerendia (Drug) $190.90
- XARELTO (Drug) $182.38
- PREVNAR - 13 (Biological) $146.74
- VRAYLAR (Drug) $139.60
- Ozempic (Drug) $125.13
- Rybelsus (Drug) $124.99
- MOUNJARO (Drug) $95.38
- JARDIANCE (Drug) $90.48
- XIFAXAN (Drug) $89.39
- Aimovig (Biological) $89.26
- UBRELVY (Drug) $85.27
- Yupelri (Drug) $71.39
- Saxenda (Drug) $64.72
- INVOKANA (Drug) $64.70
- PREVNAR 13 (Biological) $59.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681